Hui Ou Yang
Fondatore presso MingMed Biotechnology Co., Ltd.
Posizioni attive di Hui Ou Yang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Fondatore | 25/11/2019 | - |
| Direttore Tecnico/Scientifico/R&S | 19/12/2019 | - | |
| Direttore/Membro del Consiglio | 25/11/2019 | 27/07/2022 |
Storia della carriera di Hui Ou Yang
Formazione di Hui Ou Yang
| Peking University Health Science Center | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
| University of California, Los Angeles | Masters Business Admin |
Statistiche
Distribuzione geografica
| Cina | 3 |
| 2 | |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Borsa valori
- Insiders
- Hui Ou Yang
- Esperienza
